Your browser doesn't support javascript.
loading
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
Trollip, A P; Moore, D; Coronel, J; Caviedes, L; Klages, S; Victor, T; Romancenco, E; Crudu, V; Ajbani, K; Vineet, V P; Rodrigues, C; Jackson, R L; Eisenach, K; Garfein, R S; Rodwell, T C; Desmond, E; Groessl, E J; Ganiats, T G; Catanzaro, A.
Afiliación
  • Trollip AP; Biomedical Sciences, Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Medical Research Council Centre for Molecular and Cellular Biology, Stellenbosch University, Cape Town, South Africa.
  • Moore D; TB Centre and Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Laboratorio de Investigación de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Coronel J; Laboratorio de Investigación de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Caviedes L; Laboratorio de Investigación de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Klages S; Biomedical Sciences, Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Medical Research Council Centre for Molecular and Cellular Biology, Stellenbosch University, Cape Town, South Africa.
  • Victor T; Biomedical Sciences, Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Medical Research Council Centre for Molecular and Cellular Biology, Stellenbosch University, Cape Town, South Africa.
  • Romancenco E; Microbiology and Morphology Laboratory, Phthisiopneumology Institute, Chisinau, Moldova.
  • Crudu V; Microbiology and Morphology Laboratory, Phthisiopneumology Institute, Chisinau, Moldova.
  • Ajbani K; Department of Microbiology, Parmanand Deepchand Hinduja National Hospital and Medical Research Centre Tertiary Care Hospital, Mumbai, India.
  • Vineet VP; Department of Microbiology, Parmanand Deepchand Hinduja National Hospital and Medical Research Centre Tertiary Care Hospital, Mumbai, India.
  • Rodrigues C; Department of Microbiology, Parmanand Deepchand Hinduja National Hospital and Medical Research Centre Tertiary Care Hospital, Mumbai, India.
  • Jackson RL; University of California San Diego School of Medicine, La Jolla, California, USA.
  • Eisenach K; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Garfein RS; University of California San Diego School of Medicine, La Jolla, California, USA.
  • Rodwell TC; Division of Global Public Health, University of California San Diego School of Medicine, La Jolla, California, USA.
  • Desmond E; Mycobacteriology and Mycology Section, Microbial Diseases Laboratory, California Department of Public Health, Richmond, California, USA.
  • Groessl EJ; University of California San Diego, Veterans' Affairs San Diego Healthcare System, La Jolla, California, USA.
  • Ganiats TG; University of California San Diego Health Services Research Center, UCSD, La Jolla, California, USA.
  • Catanzaro A; University of California San Diego School of Medicine, La Jolla, California, USA.
Int J Tuberc Lung Dis ; 18(2): 227-32, 2014 Feb.
Article en En | MEDLINE | ID: mdl-24429318
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Pruebas de Sensibilidad Microbiana / Tuberculosis Resistente a Múltiples Medicamentos / Farmacorresistencia Bacteriana Múltiple / Microscopía / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Africa / America do sul / Asia / Europa / Peru Idioma: En Revista: Int J Tuberc Lung Dis Año: 2014 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Pruebas de Sensibilidad Microbiana / Tuberculosis Resistente a Múltiples Medicamentos / Farmacorresistencia Bacteriana Múltiple / Microscopía / Mycobacterium tuberculosis / Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Africa / America do sul / Asia / Europa / Peru Idioma: En Revista: Int J Tuberc Lung Dis Año: 2014 Tipo del documento: Article País de afiliación: Sudáfrica